- Home
- HBNC vs PSTX Comparison
HBNC vs PSTX Comparison
Compare HBNC & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- PSTX
- Stock Information
- Founded
- HBNC 1873
- PSTX 2014
- Country
- HBNC United States
- PSTX United States
- Employees
- HBNC N/A
- PSTX N/A
- Industry
- HBNC Major Banks
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HBNC Finance
- PSTX Health Care
- Exchange
- HBNC Nasdaq
- PSTX Nasdaq
- Market Cap
- HBNC 809.8M
- PSTX 909.4M
- IPO Year
- HBNC N/A
- PSTX 2020
- Fundamental
- Price
- HBNC $16.98
- PSTX $9.52
- Analyst Decision
- HBNC Hold
- PSTX Hold
- Analyst Count
- HBNC 3
- PSTX 3
- Target Price
- HBNC $16.33
- PSTX $9.00
- AVG Volume (30 Days)
- HBNC 157.1K
- PSTX 2.6M
- Earning Date
- HBNC 01-22-2025
- PSTX 11-07-2024
- Dividend Yield
- HBNC 3.60%
- PSTX N/A
- EPS Growth
- HBNC N/A
- PSTX N/A
- EPS
- HBNC 0.48
- PSTX N/A
- Revenue
- HBNC $183,718,000.00
- PSTX $150,858,000.00
- Revenue This Year
- HBNC N/A
- PSTX $131.92
- Revenue Next Year
- HBNC $13.76
- PSTX N/A
- P/E Ratio
- HBNC $36.80
- PSTX N/A
- Revenue Growth
- HBNC N/A
- PSTX 203.18
- 52 Week Low
- HBNC $11.18
- PSTX $1.87
- 52 Week High
- HBNC $19.18
- PSTX $9.58
- Technical
- Relative Strength Index (RSI)
- HBNC 46.33
- PSTX 88.59
- Support Level
- HBNC $17.26
- PSTX $9.35
- Resistance Level
- HBNC $17.95
- PSTX $9.56
- Average True Range (ATR)
- HBNC 0.42
- PSTX 0.08
- MACD
- HBNC -0.15
- PSTX -0.09
- Stochastic Oscillator
- HBNC 16.08
- PSTX 76.67
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.